Allocations
Despite the second wave of the Covid-19 pandemic and slow economic recovery, global venture capital (VC) investments during the fourth quarter (Q4) of 2020 remained robust and were nearly at pre-pandemic levels.
Albeit, the number of VC deals witnessed a continuous decline for the seventh straight quarter, there was an increase in the number of megadeals that helped to drive the overall investment value to nearly USD120 billion in Q4, says GlobalData, a leading data and analytics company.
Venkata Naveen, Senior Disruptive Tech Analyst at GlobalData, says: “The Covid-19 pandemic has changed the game of how companies across industries operate,
Enhanced Healthcare Partners (EHP), a healthcare-focused private equity firm, has exited its platform investment in SCA Pharmaceuticals (SCA Pharma) through the sale of the business to The Vistria Group and Excellere Capital Management.
An FDA 503(B) outsourcing facility, SCA Pharma delivers sterile admixtures and pre-filled syringes to hospitals and health systems nationwide. SCA alleviates common problems health care facilities face such as wasted product, drug shortages, time-consuming processes, compliance issues, staffing costs, and patient safety concerns. Over the past five years, the Company has deeply invested in facility expansion, infrastructure, automation and quality to support the Company’s growth.
SCA
CDC Group, a UK-based impact investor and development finance institution (DFI), has announced a commitment to invest over USD1 billion again in African businesses in 2021.
The commitment will enable CDC to invest in many more promising African entrepreneurs and SMEs, and continue to drive inclusive growth and job creation across the continent, where over half of the institution’s portfolio is now invested. The funds will be invested in financial institutions, infrastructure and climate, services, manufacturing, agriculture, real estate and technology.
In 2020, CDC committed over USD1 billion into Africa with a focus was the economic recovery from
Funds managed by Clayton, Dubilier & Rice (CD&R) are partnering with current owners and management of S&S Activewear to acquire the North American distributor of imprintable apparel and accessories. Terms of the transaction have not been disclosed.
With approximately four million square feet of warehouse space and more than 2,000 employees, S&S specialises in distributing blank sportswear, corporate apparel, and accessories, including t-shirts, fleece & sweatshirts, headwear, athletics and outerwear from over 100 leading brands such as adidas, Champion, Columbia, Bella+Canvas, Next Level Apparel and Gildan. The company stocks more than 80,000 products and serves a broad range of customers,
Carey Olsen’s Jersey funds team has advised the Swiss investment advisor Montana Capital Partners AG on the launch of its fifth secondary fund, mcp Opportunity Secondary Programme V (mcp OSP V), which recently held its final closing at a hard cap of EUR1.3 billion in committed capital.
Significant support from existing and new investors led to substantial oversubscription during a brief fundraising period. Investors include sovereign wealth funds, pension funds, insurance companies, family offices and foundations from Europe, Asia, the Middle East and the United States.
mcp OSP V takes advantage of the Island’s tried and tested Jersey Expert
Big Issue Invest, the social investment arm of The Big Issue, and the University of Oxford’s Government Outcomes Lab (GO Lab) within the Blavatnik School of Government, have release the ‘Exploring Social Investment – An Indigo Technical & Learning Report’ detailing their collaboration towards data sharing in the social outcomes contract sector.
The report showcases how Big Issue Invest (BII) and GO Lab worked together to publish the contract, finance and impact data for the investments made within Big Issue Invests’ Outcomes Investment Fund (OIF).
The report launch coincides with GO Lab’s launch of the ‘International Network for Data on
BGF has invested GBP4 million in fast-growing UK homecare business CSN Care Group (CSN) to support the company with its longer-term growth plans.
CSN is a leading social care provider which operates a national network of owned and franchised branches across the UK with headquarters in Edinburgh and Milton Keynes. Its care brands include Carewatch, MyLife and New Directions.
The business was founded by Executive Chairman, Scott Christie, and Managing Director, Craig Hendry, in January 2019 as a result of a management buyout of part of the Carewatch Group. Since the MBO the Group has grown significantly to deliver more
Neuberger Berman has launched the NB Crossroads Private Markets Access Fund, a registered, continually offered closed-end fund that ‘further democratises the firm’s private equity offerings and increases access to these important portfolio solutions for individual investors’.
Read the full story at Wealth Adviser…
Jersey Finance, in conjunction with Durrell Wildlife Conservation Trust, is formally launching a new initiative today, aimed at protecting wildlife and ‘re-wilding’ ecosystems around the world.
The ‘Jersey Fund for a Wilder World’ is being officially launched at Jersey Finance’s Annual Review today, with the objective of effecting positive change on the restoration of global ecosystems, and is designed to give financial services firms in Jersey the opportunity to contribute a portion of their fees earned from sustainable finance workflows to a pooled central pot.
Contributing to the fund is voluntary, and is initially open to fund service providers, including
Singapore-based Tower Capital Asia has held a first closing of its Southeast Asia-focused private equity fund, Tower Capital PE Fund , at approximately USD250 million.
The fund’s first-closing investors include a pre-eminent international institutional investor and highly respected single family offices from the Southeast Asian region.
Danny Koh, Founder and Chief Executive Officer, says: “We are very grateful to our investors for their support, which remained unwavering through an unusually difficult fundraising year for general partners globally. The closing of the Fund marks many firsts for us, but our earliest days as a modest team spun out from a
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
